MétaCan
Menu
← Back to cohort
Record W2914081440 · doi:10.1093/ecco-jcc/jjy222.775

P651 Disease severity and intensity of therapy predicts serious adverse events in paediatric ulcerative colitis: the DEVELOP experience

2019· article· en· W2914081440 on OpenAlexaboutno aff
Harland S. Winter, James Izanec, Christopher Busse, Y Wang, Jeffrey S. Hyams

Bibliographic record

VenueJournal of Crohn s and Colitis · 2019
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineUlcerative colitisInfliximabInternal medicineInflammatory bowel diseaseAdverse effectProportional hazards modelHazard ratioMedical recordPopulationObservational studyDiseasePhysical therapyConfidence interval

Abstract

fetched live from OpenAlex

DEVELOP is a multi-centre (USA, Canada, European Union), prospective, observational registry of the long-term safety and clinical status of 6070 paediatric patients with inflammatory bowel disease (IBD including 1678 ulcerative colitis [UC] patients) treated with anti-tumour necrosis factor biologics (aTNF) and/or other medical therapies as part of physician dictated clinical care. AIM: To identify covariates that were significant predictors to time to first serious adverse event (SAE) in patients with UC. A SAE is defined as any undesirable experience that results in hospitalisation, requires medical intervention or is otherwise life-threatening. Physicians participating in the registry prescribe IBD treatments based on their usual clinical practice and standards of care. Patients are categorised into cohorts according to their IBD medication exposure. The cohorts represent prevalent or incident exposure, including patients receiving therapy prior to enrolment and patients receiving therapy during registry follow-up. Enrolment was targeted such that about 50% of the initial population had been exposed to originator infliximab. Hazard ratio (HR) for SAE was calculated by stepwise Cox regression modelling. Time to first SAE are shown in Table 1. This includes 1121 UC patients who were exposed to aTNFs as the only biologic and/or non-biologics and had at least 1 post-baseline follow-up visit, complete baseline covariate data, and complete disease severity data (partial Mayo score) at event or censoring. The covariates that were significantly associated with a shorter duration of time to first SAE in UC patients included combination therapy with aTNF/immunomodulators (IMM) and corticosteroids (CS) or combination therapy with aTNF and CS. Monotherapy with CS, disease activity (hazard ratio [HR] 2.657) and recent hospitalisation were also significantly associated. Conversely, combination therapy with aTF and IMM or monotherapy with aTNF or IMM alone were not associated with significantly increased risk of time to first SAE. In terms of HR, disease severity was the strongest predictor of time to first SAE. Combination therapy with aTNF and CS and also triple therapy with aTNF, CS and IMM were predictors as was monotherapy with CS. On the other hand, monotherapy with aTNF or with IMM were not found to be significant predictors.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.007
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.007
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.006
GPT teacher head0.229
Teacher spread0.224 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Crohn s and Colitis→Same topicInflammatory Bowel Disease→French-language works237,207→